A carregar...

Sustained Complete Response after Maintenance Therapy with Topotecan and Erlotinib for Recurrent Cervical Cancer with Distant Metastases

INTRODUCTION: Recurrent cervical cancer is associated with a poor prognosis. Most treatment responses are partial and of short duration. The development of new therapies is vital to improve treatment for recurrent disease. Epidermal growth factor receptor (EGFR) inhibitors may have a role in this se...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Callegaro-Filho, Donato, Kavanagh, John J., Nick, Alpa M., Ramirez, Pedro T., Schmeler, Kathleen M.
Formato: Artigo
Idioma:Inglês
Publicado em: S. Karger AG 2014
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3934679/
https://ncbi.nlm.nih.gov/pubmed/24575024
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000358916
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!